104869-26-3
Chemical Structure
NF157
- CAS No.: 104869-26-3
- Formula:C49H28F2N6Na6O23S6
- Molecular Weight:1437.10
IUPAC Name: sodium 8,8'-((3,3'-((3,3'-(carbonylbis(azanediyl))bis(benzoyl))bis(azanediyl))bis(4-fluorobenzoyl))bis(azanediyl))bis(naphthalene-1,3,5-trisulfonate)
InChIKey: PFKJKZYADCSCBI-UHFFFAOYSA-H
SMILES: O=C(NC1=CC(C(NC2=CC(C(NC3=CC=C(S(=O)(O[Na])=O)C4=CC(S(=O)(O[Na])=O)=CC(S(=O)(O[Na])=O)=C34)=O)=CC=C2F)=O)=CC=C1)NC5=CC(C(NC6=CC(C(NC7=CC=C(S(=O)(O[Na])=O)C8=CC(S(=O)(O[Na])=O)=CC(S(=O)(O[Na])=O)=C78)=O)=CC=C6F)=O)=CC=C5
Biological Activity: NF157 is a highly selective nanomolar P2Y11 antagonist with a pKi of 7.35. The IC50s are 463 nM, 1811 µM, 170 µM for P2Y11 (Ki=44.3 nM), P2Y1 (Ki=187 µM), P2Y2 (Ki=28.9 µM), respectively[1]. NF157, significantly reduces expression of metalloproteinase (MMP)-3, MMP-13, can be used in the treatment of osteoarthritis (OA)[2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
NF157 | 99.13% | NF157 is a highly selective nanomolar P2Y11 antagonist with a pKi of 7.35. The IC50s are 463 nM, 1811 µM, 170 µM for P2Y11 (Ki=44.3 nM), P2Y1 (Ki=187 µM), P2Y2 (Ki=28.9 µM), respectively. NF157, significantly reduces expression of metalloproteinase (MMP)-3, MMP-13, can be used in the treatment of osteoarthritis (OA). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.89
HY-B0879ARSuramin sodium salt (Standard) -
Similarity Score 0.82
HY-108676NF023 hexasodium -
Similarity Score 0.78
HY-D0976NF279 -
Similarity Score 0.74
HY-B0879Suramin -
Similarity Score 0.68
HY-130284NF864 -
Similarity Score 0.66
HY-167704NF023 -
Similarity Score 0.61
HY-112461ANF449 octasodium -
Similarity Score 0.59
HY-108659NF340 -
Similarity Score 0.55
HY-135605PNU-145156E -
Explore the MedChemAI to find more analogs
References
- [1]. Ullmann H, et al. Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency. J Med Chem. 2005 Nov 3;48(22):7040-8. [Content Brief]
- [2]. Wang D, et al. Inhibition of P2Y11R ameliorated TNF-α-induced degradation of extracellular matrix in human chondrocytic SW1353 cells. Am J Transl Res. 2019 Apr 15;11(4):2108-2116. [Content Brief]
